Governance InnoCan Pharma Corporation

INNO

CA45783P5085

Pharmaceuticals

Market Closed - Canadian Securities Exchange Other stock markets 03:50:45 2025-12-16 pm EST			5-day change	1st Jan Change
7.500 ^CAD	0.00%		-30.56%	-45.05%

Dec. 10	InnoCan Announces Public Filing of Amended Registration Statement For Proposed U.S. Offering	MT
Nov. 27	Innocan Pharma Nine-month Operating Loss Stable, Revenue Fall 10%	MT

Executive Committee: InnoCan Pharma Corporation

Manager

Positions heldSince

Iris Bincovich

Chief Executive Officer	2018-05-30
Founder	2018-05-30
Public Communications Contact	2018-05-30

Nir Avram

72 year

Chief Tech/Sci/R&D Officer	-
Founder	-

Eyal Flom

60 year

Corporate Secretary

2020-01-21

Nelson Halpern

Director of Finance/CFO

2019-02-19

Roni Kamhi

Chief Operating Officer

2022-08-10

Eyal Kalo

Chief Tech/Sci/R&D Officer

2023-04-30

Composition of the Board of Directors: InnoCan Pharma Corporation

Director

CommitteesSince

Iris Bincovich

Chairman

2025-06-30

Eyal Flom

60 year

Audit Committee	2019-09-24
Compensation Committee	2019-09-24

Joshua Lintern

38 year

Audit Committee	2019-09-29
Compensation Committee	2019-09-29

Peter Bloch

65 year

Audit Committee

2024-12-08

Roni Kamhi

Director/Board Member

Ralph Bossino

Director/Board Member

2019-09-29

Latest Appointments: InnoCan Pharma Corporation

Jul. 03	Chair of Innocan Pharma Resigns	MT
Jul. 03	InnoCan Pharma Corporation Announces Executive Changes, Effective July 1, 2025	CI
23-09-15	InnoCan Pharma Corporation Announces Appointment of Dr. Joseph V. Pergolizzi to its Scientific Advisory Board	CI
22-11-18	Innocan Pharma Corporation Announces the Addition of Givi Topchishvili, to Advisory Committee, as A Business Strategy Adviser	CI
22-08-11	InnoCan Pharma Corporation Appoints Roni Kamhi as Chief Operating Officer	CI
22-02-07	Innocan Pharma Corporation Announces Appointment of Dr. Kenji Kitatani to Advisory Committee	CI
21-07-14	Iinnocan Pharma Corporation Announces Addition of Izhar Shay to its Advisory Committee	CI

More news

Former Officers and Directors: InnoCan Pharma Corporation

Insider

Positions held

SinceUntil

Ron Abraham Mayron

Chairman

2017-10-31

2025-06-30

Yoram Drucker

Director/Board Member	2018-05-30	2023-05-31
Founder	2018-05-30	2023-05-31
Corporate Officer/Principal	2018-05-30	2023-05-31

Daryl Fridhandler

Director/Board Member	2018-05-30	2020-01-21
Independent Dir/Board Member	2018-05-30	2020-01-21
Corporate Secretary	2018-05-30	2020-01-21

William MacDonald

Director/Board Member	2018-07-31	-
Independent Dir/Board Member	2018-07-31	-

Moshe Hukaylo

Director of Finance/CFO

Izhar Shay

Director/Board Member

Age distribution of managers

Parity Men Women

Male	9
Female	1

Of which Executive Committee

Male	5
Female	1

Of which Directors

Male	5
Female	1

Innocan Pharma Corporation is an Israel-based company active in the pharmaceuticals and wellness sectors. In the pharmaceuticals sector, the Company aims to provide a safe, non-opioid chronic pain management solutions for both animals and humans. To achieve this aim, the Company developed a CBD-loaded liposome drug delivery platform with exact dosing, prolonged and controlled release of synthetic CBD for non-opioid pain management. In the wellness sector, the Company develops and markets a wide portfolio of high-performance self-care and beauty products to promote a healthier lifestyle. Under this segment Innocan established a Joint Venture (BI Sky Global Ltd.) that focused on advanced, targeted online sales.

Employees

Sector

Pharmaceuticals

Calendar

Mar. 25 - Q4 2025 Earnings Release (Projected)

More about the company